Histone Deacetylase Inhibitor Romidepsin Inhibits De Novo HIV-1 Infections
Kasper L Jonsson, Martin Tolstrup, Johan Vad-Nielsen, Kathrine Kjaer, Anders Laustsen, Morten N Andersen, Thomas A Rasmussen, Ole S Sogaard, Lars Ostergaard, Paul W Denton, Martin R Jakobsen
Antimicrobial Agents and Chemotherapy | AMER SOC MICROBIOLOGY | Published : 2015
Awarded by Danish Strategic Research Council
Awarded by Danish Research Council
This study was supported in part by the Lundbeck Foundation (K.L.J. and M.R.J.), Aarhus University Research Foundation (M.R.J.), Danish Strategic Research Council grant 0603-00521B (L.O.), and Danish Research Council grant 12-133887 (O.S.S.). The funders had no role in study design, data collection, and analysis, decision to publish, or writing of the manuscript. The following reagents were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: TZM-bl cells (John C. Kappes, Xiaoyun Wu, and Tranzyme, Inc.), ACH-2 cells (Thomas Folks), and MOLT-4/CCR5 cells (Masanori Baba, Hiroshi Miyake, and Yuji Iizawa).